No effect of sirolimus for kaposi sarcoma in a renal transplant recipient.

Suppr

超能文献

作者信息

Descoeudres Bernard, Giannini Olivier, Graf Tanja, Steiger Jürg, Mayr Michael

出版信息

Transplantation. 2006 May 27;81(10):1472-4. doi: 10.1097/01.tp.0000203322.99037.d2.

DOI:10.1097/01.tp.0000203322.99037.d2

PMID:16732189

Abstract

摘要

相似文献

No effect of sirolimus for kaposi sarcoma in a renal transplant recipient.

Transplantation. 2006 May 27;81(10):1472-4. doi: 10.1097/01.tp.0000203322.99037.d2.

A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.一种新型免疫抑制剂西罗莫司治疗肾移植受者的卡波西肉瘤。

Ren Fail. 2007;29(1):103-5. doi: 10.1080/08860220601039528.

Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment.西罗莫司治疗经典型地中海卡波西肉瘤出现消退

Arch Dermatol. 2008 May;144(5):692-3. doi: 10.1001/archderm.144.5.692.

Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient.西罗莫司用于肾移植受者的内脏和皮肤卡波西肉瘤

Clin Exp Nephrol. 2007 Sep;11(3):251-254. doi: 10.1007/s10157-007-0470-y. Epub 2007 Sep 28.

Sirolimus and regression of Kaposi's sarcoma in immunosuppressed transplant patient.

J Eur Acad Dermatol Venereol. 2008 Aug;22(8):1022-3. doi: 10.1111/j.1468-3083.2007.02536.x. Epub 2008 Jan 10.

Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.西罗莫司对新发恶性肿瘤的肾移植受者的抗癌作用。

Transplant Proc. 2007 Nov;39(9):2736-9. doi: 10.1016/j.transproceed.2007.08.078.

Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient.雷帕霉素用于骨髓移植受者的卡波西肉瘤和移植物抗宿主病

Transplantation. 2010 Mar 15;89(5):633-4. doi: 10.1097/TP.0b013e3181c892c3.

Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma.监测雷帕霉素对卡波西肉瘤的抗肿瘤疗效。

Am J Kidney Dis. 2007 Mar;49(3):462-70. doi: 10.1053/j.ajkd.2006.11.037.

Regression of post-transplant Kaposi's sarcoma using sirolimus.使用西罗莫司使移植后卡波西肉瘤消退。

Int J Clin Pract. 2006 Nov;60(11):1509-12. doi: 10.1111/j.1742-1241.2006.00815.x.

Immunosuppressive drugs and the risk of cancer after organ transplantation.免疫抑制药物与器官移植后患癌风险

N Engl J Med. 2005 Mar 31;352(13):1371-3. doi: 10.1056/NEJMe058018.

引用本文的文献

Oral-visceral iatrogenic Kaposi sarcoma following treatment for acute lymphoblastic leukemia: a case report and review of the literature.口腔内脏医源性卡波西肉瘤继发于急性淋巴细胞白血病治疗后：病例报告及文献复习。

J Med Case Rep. 2022 Nov 4;16(1):405. doi: 10.1186/s13256-022-03620-3.

Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.第 10 号染色体上的磷酸酶和张力蛋白同源物在原发性渗出性淋巴瘤和卡波西肉瘤中发生磷酸化。

Am J Pathol. 2011 Oct;179(4):2108-19. doi: 10.1016/j.ajpath.2011.06.017. Epub 2011 Aug 3.

De novo and recurrent Kaposi's Sarcoma after renal transplantation in two patients taking everolimus.两名服用依维莫司的肾移植患者发生的新发和复发性卡波西肉瘤。

Hippokratia. 2008 Jul;12(3):191-2.

Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.双重抑制PI3Kα和mTOR作为卡波西肉瘤的替代治疗方法。

Cancer Res. 2008 Oct 15;68(20):8361-8. doi: 10.1158/0008-5472.CAN-08-0878.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验